BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 10896378)

  • 1. Adenocarcinoma of the esophagus with and without Barrett mucosa.
    Sabel MS; Pastore K; Toon H; Smith JL
    Arch Surg; 2000 Jul; 135(7):831-5; discussion 836. PubMed ID: 10896378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review.
    Shaheen N; Ransohoff DF
    JAMA; 2002 Apr; 287(15):1972-81. PubMed ID: 11960540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adenocarcinoma of the esophagogastric junction: association with Barrett esophagus and gastroesophageal reflux--surgical results in 122 patients].
    Schumpelick V; Dreuw B; Ophoff K; Fass J
    Leber Magen Darm; 1996 Mar; 26(2):75-6, 79-80, 83-6. PubMed ID: 8684248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the clinical and histological characteristics and survival of distal esophageal-gastroesophageal junction adenocarcinoma in patients with and without barrett mucosa.
    Portale G; Peters JH; Hagen JA; Demeester SR; Gandamihardja TA; Tharavej C; Hsieh CC; Demeester TR
    Arch Surg; 2005 Jun; 140(6):570-4; discussion 574-5. PubMed ID: 15967904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.
    Agarwal B; Swisher SG; Ajani J; Kelly K; Komaki RR; Abu-Hamda E; Correa AM; Roth JA
    Ann Thorac Surg; 2005 May; 79(5):1716-23. PubMed ID: 15854962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SESAP questions. Gastroesophageal reflux disease.
    Can J Surg; 1999 Dec; 42(6):472-4. PubMed ID: 10593253
    [No Abstract]   [Full Text] [Related]  

  • 7. Adenocarcinoma in the distal esophagus with and without Barrett esophagus. Differences in symptoms and survival rates.
    Johansson J; Johnsson F; Walther B; Willén R; Staël von Holstein C; Zilling T
    Arch Surg; 1996 Jul; 131(7):708-13. PubMed ID: 8678768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barrett esophagus: will effective treatment prevent the risk of progression to esophageal adenocarcinoma?
    Sharma P
    Am J Med; 2004 Sep; 117 Suppl 5A():79S-85S. PubMed ID: 15478857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia.
    Anandasabapathy S; Jhamb J; Davila M; Wei C; Morris J; Bresalier R
    Cancer; 2007 Feb; 109(4):668-74. PubMed ID: 17211862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis.
    Inadomi JM; Sampliner R; Lagergren J; Lieberman D; Fendrick AM; Vakil N
    Ann Intern Med; 2003 Feb; 138(3):176-86. PubMed ID: 12558356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reflux disease and Barrett's esophagus.
    Koop H
    Endoscopy; 2000 Feb; 32(2):101-7. PubMed ID: 10696837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnosis and management of Barrett's esophagus.
    DeMeester SR; DeMeester TR
    Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
    Endzinas Z; Mickevicius A; Kiudelis M
    Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic alterations in Barrett esophagus and adenocarcinomas of the esophagus and esophagogastric junction region.
    Wu TT; Watanabe T; Heitmiller R; Zahurak M; Forastiere AA; Hamilton SR
    Am J Pathol; 1998 Jul; 153(1):287-94. PubMed ID: 9665490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac rather than intestinal-type background in endoscopic resection specimens of minute Barrett adenocarcinoma.
    Takubo K; Aida J; Naomoto Y; Sawabe M; Arai T; Shiraishi H; Matsuura M; Ell C; May A; Pech O; Stolte M; Vieth M
    Hum Pathol; 2009 Jan; 40(1):65-74. PubMed ID: 18755496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited.
    Lada MJ; Nieman DR; Han M; Timratana P; Alsalahi O; Peyre CG; Jones CE; Watson TJ; Peters JH
    Surgery; 2013 Oct; 154(4):856-64; discussion 864-6. PubMed ID: 24074425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early esophageal carcinoma: diagnosis and endoscopic therapy].
    Ell C
    Z Gastroenterol; 2002 Dec; 40 Suppl 2():12-4. PubMed ID: 12466997
    [No Abstract]   [Full Text] [Related]  

  • 18. Barrett esophagus and risk of esophageal cancer: a clinical review.
    Spechler SJ
    JAMA; 2013 Aug; 310(6):627-36. PubMed ID: 23942681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
    Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
    Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients With Esophageal Adenocarcinoma With Prior Gastroesophageal Reflux Disease Symptoms Are Similar to Those Without Gastroesophageal Reflux Disease: A Cross-Sectional Study.
    Chandar AK; Keerthy K; Gupta R; Grady WM; Canto MI; Shaheen NJ; Thota PN; Iyer PG; Wang JS; Falk GW; Abrams JA; Dumot J; Faulx A; Markowitz SD; Willis J; Moinova H; Guda K; Brock W; Chak A
    Am J Gastroenterol; 2024 May; 119(5):823-829. PubMed ID: 37975600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.